BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Capelle CM, Ciré S, Domingues O, Ernens I, Hedin F, Fischer A, Snoeck CJ, Ammerlaan W, Konstantinou M, Grzyb K, Skupin A, Carty CL, Hilger C, Gilson G, Celebic A, Wilmes P, Del Sol A, Kaplan IM, Betsou F, Abdelrahman T, Cosma A, Vaillant M, Fagherazzi G, Ollert M, Hefeng FQ. Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patients. Cell Rep Med 2022;3:100600. [PMID: 35480624 DOI: 10.1016/j.xcrm.2022.100600] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Fischer A, Badier N, Zhang L, Elbéji A, Wilmes P, Oustric P, Benoy C, Ollert M, Fagherazzi G. Long COVID Classification: Findings from a Clustering Analysis in the Predi-COVID Cohort Study. Int J Environ Res Public Health 2022;19. [PMID: 36498091 DOI: 10.3390/ijerph192316018] [Reference Citation Analysis]
2 Binayke A, Zaheer A, Dandotiya J, Gupta SK, Mani S, Tripathy MR, Madan U, Shrivastava T, Kumar Y, Pandey AK, Rathore DK, Awasthi A. Proinflammatory Innate Cytokines and Distinct Metabolomic Signatures Shape the T Cell Response in Active COVID-19. Vaccines 2022;10:1762. [DOI: 10.3390/vaccines10101762] [Reference Citation Analysis]
3 da Silva ES, Kohnen M, Gilson G, Staub T, Arendt V, Hilger C, Servais J, Charpentier E, Domingues O, Snoeck CJ, Ollert M, Seguin-devaux C, Perez-bercoff D. Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone. IJMS 2022;23:7675. [DOI: 10.3390/ijms23147675] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Santos da Silva E, Kohnen M, Gilson G, Staub T, Arendt V, Hilger C, Servais J, Charpentier E, Domingues O, Snoeck CJ, Ollert M, Seguin-devaux C, Perez-bercoff D. Pre-Omicron vaccine breakthrough infection induces superior cross-neutralization against SARS-CoV-2 Omicron BA.1 than primo infection.. [DOI: 10.1101/2022.06.21.22276659] [Reference Citation Analysis]